Abstract Recent evidence has shown that bone marrow stromal cells (BMSCs) may exhibit immuno-suppression activities through soluble mediators and direct cell-cell contact, but how these processes are modulated has been poorly understood. In this study, we show that the Notch signaling pathway participates in the modulation of BMSCs to elicit their immuno-suppressive roles. In a murine lethal acute graft versus host disease (aGvHD) model, BMSCs deficient for RBP-J, the critical transcription factor mediating signaling from all four mammalian Notch receptors, failed to delay the development of the disease. RBP-J deficient BMSCs were not able to inhibit the proliferation and activation of allogenic T-cells. Moreover, RBP-J deficient BMSCs could not down-regulate the expression of MHC II and co-stimulation molecules CD80 and CD86 on dendritic cells (DCs). The antigen presentation capacity of DCs co-cultured with RBP-J deficient BMSCs was not impaired in contrast to wild type BMSCs. Furthermore, we showed that the productions of IL-6 and PGE2, two critical molecules mediating the immuno-suppressive activities of BMSCs, were reduced significantly in RBP-J deficient BMSCs. Both of the two molecules were importantly involved in the regulation of BMSCs by Notch signaling. In conclusion, our data suggests that the immuno-suppressive effects of BMSCs in aGvHD are dependent on Notch-RBP-J signaling, which regulates the productions of IL-6 and PGE2.
Introduction
Bone marrow stromal cells (BMSCs) consist of a heterogeneous population of cells that provide the structural and functional support for hematopoietic cells (Bianco et al., 2001; Sacchetti et al, 2007) . These cells have fibroblast-like morphology, express CD29, CD44, CD73, CD90, CD105 and CD166, and are negative for CD14, CD34, and CD45 (Boxall and Jones, 2012) . Additionally, BSMC populations contain a sub-population of stem cells with the ability to differentiate into cartilage, bone, stroma that supports hematopoiesis, and marrow adipocytes (Spencer et al., 2011) .
Although inconsistency exists, recent evidence has shown that BMSCs can inhibit immune responses in different experimental and clinical settings through suppressing both innate and adaptive immune cells, such as natural killer (NK) cells, dendritic cells (DCs), B-cells, and T-cells (Yagi et al., 2010) . For example, Bartholomew et al. showed that systemic administration of autologous or allogeneic BMSCs increased the viability of allogeneic skin grafts in baboons (Bartholomew et al., 2002) . In graft-versus-host disease (GvHD), transfusion of BMSCs has been shown to attenuate the disease (Le Blanc et al., 2004 Blanc et al., , 2008 Miyake et al., 2008) . It has been further shown that BMSCs can suppress T-cell activation through cell-cell contacts and various soluble factors including transforming growth factor (TGF)-β1, hepatocyte growth factor (HGF), indoleamine 2,3-dioxygenase and prostaglandin (PG) E2, among others (Trento and Dazzi, 2010; Glennie et al., 2005; Le Blanc et al., 2003) . Moreover, BMSCs can inhibit the maturation and function of monocyte-derived DCs, likely by the production of interleukin (IL)-6, monocyte-colony stimulating factor (M-CSF), and PGE2 (Spaggiari et al., 2009; Jung et al., 2007; Kronsteiner et al., 2011; Djouad et al, 2007; Nauta et al., 2006; Zhang et al., 2009) . However, while the immunosuppressive functions of BMSCs upon systemic infusion remain to be definitively demonstrated in vivo, how these roles of BMSCs are modulated has not been fully elucidated.
Notch signaling mediates direct cell-cell communications that are essential for the proliferation and differentiation of stem/progenitor cells (Artavanis-Tsakonas et al., 1999) . In mammals, there are five Notch ligands (Delta-like [Dll] 1, 3, 4, and Jagged 1, 2) and four Notch receptors (Notch 1-4). The transcription factor RBP-J (recombination signal binding protein-Jк) mediates signaling from all four Notch receptors by associating with the Notch intracellular domain (NIC), which is released from the membrane by a γ-secretasemediated proteolytic mechanism upon receptor triggering. Transactivated RBP-J further regulates cell proliferation and differentiation by modulating downstream gene expression.
It has been shown that RBP-J-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development (Dong et al., 2010) . It was also suggested that Notch signaling played an important role during MSC-mediated inhibition of the differentiation of monocytes into DCs (Li et al., 2008b) . In this study, by using a mouse acute GvHD (aGvHD) model, we show that the immuno-suppressive function of BMSCs in aGvHD is dependent on Notch signaling, and that Notch signaling regulates the immune-suppression of BMSCs through the production of IL-6 and PGE2. Inbred C57BL/6 (H 2b ) and BALB/c (H 2d ) female mice were raised in the specific pathogen free (SPF) conditions. The animal husbandry, experiments and welfare were conducted in accordance with the Detailed Rules for the Administration (Kuhn et al., 1995) was provided by K Rajewski, and the RBP-J-floxed mouse (RBP-J f ) has been maintained in our lab (Han et al., 2002) . The Cre-mediated deletion of the floxed RBP-J exons was induced in 1-month-old RBP-J f/f -MxCre and RBP-J +/f -MxCre mice by using poly(I)-poly(C) (Sigma, St. Louis, MO) as described (Han et al., 2002) .
Materials and methods

Animals
Culture of murine BMSCs
BMSCs from murine compact bones were isolated and cultured as described previously . Briefly, mice were euthanized according the rules of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). BM was flushed from femurs and tibias, and single-cell suspension was obtained by passing through an 18-gage needle and filtered with a nylon membrane, followed by erythrolysis in buffered 0.14 M NH 4 Cl. Cells were counted and cultured in 6-well plates in DF12 medium (Invitrogen, Carlsbad, CA) containing 20% fetal calf serum (FCS) and 2 mM L-glutamine in a humidified atmosphere of 5% CO 2 at 37°C. Adherent cells were passaged routinely at 4 day intervals, and cells at passages 3-5 were used. BMSCs were treated with 50 μg/ml mitomycin C (MMC, Sigma, St. Louis, MI) at 37°C for 45 min followed by five extensive washes with cold PBS before further experiments.
DC culture
DCs were cultured as described previously . Briefly, nucleated BM cells (2 × 10 6 ) were counted and cultured in 24-well plates in 1 ml of RPMI1640 medium containing 20% FCS and 2 mM L-glutamine, and supplemented with 20 ng/ml mouse GM-CSF and 10 ng/ml mouse IL-4 (Pepro Tech, Inc.) for 9 days. Bacterial lipopolysaccharide (LPS, 1 μg/ml, Sigma) was added to the culture for 12 h to stimulate DC maturation. For transwell cultures, DCs (2 × 10 5 ) were seeded into the upper chamber (with 0.4-μm pore size, Costar) in a volume of 100 μl of RPMI1640 supplemented with 1% bovine serum albumin (BSA). BMSCs (4 × 10 4 /well) were plated in the lower chamber in 600 μl of RPMI1640. In some experiments, IL-6 (PeproTech, Rocky Hill, NJ) or an anti-IL-6 antibody (R&D Systems, Minneapolis, MN) was applied in the culture.
Flow cytometry
Single cell suspensions were prepared from cultured cells or tissues, followed by treatment with buffered 0.14 M NH 4 Cl if necessary. Cells (3 × 10 5 ) were stained with antibodies for 30 min on ice, and were analyzed by using a FACSCalibur™ flow cytometer (BD Immunocytometry Systems, San Jose, CA). Data were analyzed with the CellQuest™ software. Dead cells were excluded by propidium iodide (PI) staining. Biotinylated anti-mouse CCR7 was purchased from eBioscience (San Diego, CA). Biotinylated anti-mouse I-Ab (KH174), anti-mouse CD3-APC (17A2), anti-mouse CD4-APC (L3T4), anti-mouse CD8-APC (53-6.7), anti-mouse CD69-FITC (H1.2F3), anti-mouse CD80-FITC (16-10A1), anti-mouse CD86-PE (GL-1), anti-mouse-CD11c-FITC (N418) and anti-mouse-CD11c-PE (HL3) were from BD PharMingen (San Diego, CA). For cytoplasmic staining, cells were treated with Brefeldin A and were stained and analyzed by using a Fixation & Permeabilization Kit (eBioscience) following the recommended protocols.
Murine aGvHD model
Murine aGvHD model was established as described (Schroeder and DiPersio, 2011) . Briefly, splenic and BM mononuclear cells were prepared from female C57BL/6 mice. Splenocytes (2 × 10 7 ) and BM cells (1 × 10 7 ) were injected intravenously (i.v.) into lethally irradiated (950 cGy of γ-ray) female BALB/c mice. BMSCs from BALB/c were infused via two injections with an interval of 1 h, with the first injection performed simultaneously with the splenocytes. Each injection contained 1 × 10 6 BMSCs in 0.2 ml of phosphate-buffered saline (PBS), a procedure that has been reported to increase the pulmonary passage of BMSCs (Fischer et al., 2009 ). On days 2, 4, and 6 after the transplantation, the spleens, lymph nodes and colon of the recipient mice were harvested and analyzed.
Histology
Tissues from the aGvHD mice were taken for pathologic analysis on day 6 after transplantation. Specimens of the liver, spleen, gut, and lung were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned at 10 μm thickness, and stained with hematoxylin and eosin (H&E) by standard methods.
Mixed lymphocyte reaction
Splenic T-cells were obtained from C57BL/6 mice by negative selection with magnetic beads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) and loaded with CFSE. BMSCs were preplated in 96-well plates (5 × 10 4 /well) and irradiated with 20 Gy of γ-ray 24 h after the plating. T-cells (2 × 10 5 / well) were cultured with irradiated (20 Gy) BALB/c splenic mononuclear cells at a ratio of 1:50, in the absence or presence of BMSCs. The cultures were incubated in a total volume of 200 μl/well of medium. Five days later, cells were collected for the analysis of proliferation and expression of CD69 or IFN-γ by FACS.
Antigen uptake assay
Antigen uptake was measured by using FITC-dextran (1 mg/ml; molecular weight 40,000; Sigma). Approximately 5 × 10 5 cells were incubated in medium containing FITC-dextran for 60 min. The cells were then washed twice with cold PBS. The quantitative uptake of FITC-dextran by the cells was determined by FACS.
Antigen presentation assay C57BL/6 mice were immunized by injection intraperitoneally (i.p.) with 100 mg ovalbumin (OVA) mixed with complete Freund's adjuvant (CFA), and strengthened 7 days later with the same dose of antigen. Fifteen days after the primary immunization, T-cells were isolated from the lymph nodes through negative selection by using the Pan T-Cell Isolation Kit II (Miltenyi). Syngeneic DCs were pulsed with OVA (10 μg/ml) for 12 h, and then co-cultured with OVA-specific T-cells pre-loaded with CFSE (Molecular Probes) at the ratio of 1:10 for 5 days. The proliferation of CD4 + and CD8 + OVA-specific T-cells was detected by FACS. The CD3 + T-cells were sorted by magnetic beads, and the expressions of CD69 and IFN-γ were examined by FACS.
For in vivo assay, C57BL/6 mice were immunized with OVA by standard procedures. BM cells from GFP transgenic C57BL/ 6 mice were induced into DCs in the presence of BMSCs. Cells were trypsinized, and DCs were isolated by using anti-CD11c magnetic beads (Miltenyi). These GFP-DCs (5 × 10 5 ) were then pulsed with OVA for 12 h, and injected subcutaneously (s.c.) at the left hind footpads of the OVA-immunized mice. Meanwhile, BrdU (0.6 mg) was injected i.p. every 6 h. Draining lymph nodes were harvested 3 days later, and the proliferation of CD3 + T-cells was detected by staining with FITC-labeled anti-BrdU antibody (Sigma), followed by FACS. The expressions of CD69 and IFN-γ by CD3
+ T-cells were also examined by FACS.
To detect the influence of BMSCs on mature DCs in vivo, GFP-DCs (5 × 10 5 ) cultured without BMSCs were injected s.c. at the left hind footpads of OVA-immunized mice, and then 2 × 10 6 BMSCs were injected i.v. 15 min later via two injections as described above. Mice were observed as above.
In vivo allo-delayed type hypersensitivity (DTH) assay
Allo-DTH was performed as reported previously . Briefly, BALB/c mice were immunized on the dorsal trunk by inoculation s.c. with C57BL/6 splenocytes (10 8 cells/ mouse), and re-challenged 7 and 14 days later at the hind footpads by injecting the same cells (10 8 cells/mouse). DCs (3 × 10 6 cells/mouse) from C57BL/6 mice were injected i.p. on days −6, − 4, 0, 3, and 6. Footpad thickness was measured on days 8 and 15 with a caliper-type engineer's micrometer by a third experimenter who is blind of the sample identity. The extent of swelling was calculated as the thickness of the right footpad (receiving C57BL/6 splenocytes) minus the baseline thickness of the left footpad (receiving BALB/C splenocytes).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was prepared from cultured cells and reversetranscribed to generate cDNA. Real-time PCR was performed by using a kit (SYBR Premix EX Taq, Takara) and the ABI PRISM 7500 Real-time PCR system. Primers used in real-time PCR were as follows: IL-6 (NM031168): 5′CTCTGGGAAATCGTGGAAATG and AAGTGCATCATCGTTGTTCATACA; β-actin (NM007393): 5′CATC CGTAAAGACCTCTATGCCAAC and 5′-ATGGAGCCACCGATCCACA.
Western blot
Whole cell extracts were prepared by lysing cells with the RIPA buffer (50 mM Tris-HCl, pH 7.9, 150 mM NaCl, 0.5 mM EDTA, and 0.5% Nonidet P-40, 0.1 mM phenylmethylsulfonyl fluoride). Proteins were separated by SDS-PAGE with 12% polyacrylamide, and electroblotted onto polyvinylidene difluoride (PVDF) membrane. Membranes were probed by using rabbitanti-mouse P-Stat3, Stat3, P-Akt and Akt (Thermo Fisher Scientific, Fremont, CA), and monoclonal anti-β-actin (AC-74, Sigma) at appropriate dilutions, followed by incubation with horseradish peroxidase-conjugated secondary anti-rabbit or anti-mouse IgG antibody (Sigma). Blots were developed by using an enhanced chemiluminescence system (Roche Applied Science).
Enzyme-linked immunosorbnent assay (ELISA)
The culture supernatants were collected, and were used to detect cytokines and PGE2 by using different assay kits (Jinmei Biotec, Shen Zhen, China). OD 450 was recorded using a spectrophotometer.
Statistics
The statistical analysis was performed with the SPSS 12.0 program. Results were expressed as the means ± SD. The comparisons between groups were undertaken using the unpaired Student's t-test. P b 0.05 was considered statistically significant.
Results
BMSCs from RBP-J knockout mice failed to delay lethal aGvHD in vivo ) as controls (Han et al., 2002) . Injection of poly(I)-poly(C) induced almost complete deletion of the floxed RBP-J exons in BMSCs (Xie et al., 2013) . No significant difference in cell proliferation or apoptosis was detected between RBP-J −/− and RBP-J +/− BMSCs (data not shown). The wild type, RBP-J +/− and RBP-J −/− BMSCs expressed similar levels of CD29, CD44, CD90, CD106 and Sca-1, and did not express F4/80, CD11b, CD34, CD45, CD117 or MHC II (supplementary Fig. S1 ). The secretion of IL-8, TGF-β, matrix metalloproteinase (MMP)-2, -9, and thrombospondin (TSP)-1 was comparable between the RBP-J deficient and control BMSCs. The expressions of VEGF, IL-6, and PGE2 were reduced when Notch signaling was blocked (supplementary Fig. S2 ).
To determine the roles of Notch signaling in BMSCs to regulate the development of lethal aGvHD, spleen and BM mononuclear cells derived from C57BL/6 were injected i.v. into lethally irradiated BALB/c mice, with or without BMSCs of different genotypes injected simultaneously. Because previous reports have shown that intravenously injected BMSCs are initially trapped in the lung (Lee et al., 2009; Fischer et al., 2009) , the distribution of BMSCs after intravenous injection in aGvHD mice was analyzed firstly (supplementary Fig. S3 ). While many of the injected BMSCs were trapped in the lung, a substantial fraction of cells could be found in the spleens and other organs of the recipient mice 2 days after the injection. The result showed that while RBP-J +/− BMSCs (BMSCs +/− ) significantly prolonged the survival of aGvHD mice, RBP-J −/− BMSCs (BMSCs −/− ) failed to do so (Fig. 1A) . Both aGvHD mice without cell therapy and treated with BMSCs −/− showed ruffled fur, a representative symptom of aGvHD (Le Blanc et al., 2004) , which was alleviated significantly by the BMSCs +/− injection (Fig. 1B) . Histological examination of livers, lungs, and colons, three target organs of aGvHD, showed heavy lymphocyte infiltration in mice without cell therapy (Fig. 1C) . Although treatment with BMSCs +/− remarkably reduced cell infiltration, BMSCs
showed no therapeutic effect on cell infiltration in liver, lung, or colon in the aGvHD mice. Examination of serum inflammatory cytokines including IL-6, IL-12, TNF-α and IFN-γ showed that infusion of BMSCs +/− strongly reduced cytokine levels compared with the group without cell therapy, but mice treated with BMSCs −/− exhibited similar cytokine levels with the group without cell therapy (Fig. 1D) .
BMSCs can enhance donor-derived CD3 + cells to homing to secondary lymphoid organs in aGvHD (Li et al., 2008a; Hasegawa et al., 2000) . We therefore examined donorderived CD3 + cell distribution in the recipient mice during aGvHD. Compared with the aGvHD mice without cell therapy, infusion of BMSCs +/− significantly increased donor-derived CD3 + cells in spleens and lymph nodes of the recipient mice. However in aGvHD mice accepting BMSCs −/− , donor-derived CD3 + cells in the secondary lymphoid organs were at the similar level as in aGvHD mice without cell therapy (Fig. 1E,  supplementary Fig. S4 ). In contrast, BMSCs +/− reduced the homing of donor-derived CD3 + cells in colon, but infusion of BMSCs −/− cells did not influence the homing of donor-derived CD3 + cells in the colon of aGvHD mice (Fig. 1E, supplementary  Fig. S4 ). These data suggested that RBP-J dependent Notch signaling was required for BMSCs to exert their immuneregulatory roles in aGvHD.
RBP-J KO canceled the suppression of T-cell activation by BMSCs in vitro
BMSCs efficiently suppress the proliferation and activation of T-cells (Tse et al., 2003; Di Nicola et al., 2002) . To examine the role of Notch signaling in this process, we performed MLR in the presence of BMSCs +/− or BMSCs , in contrast, failed to downregulate the expression of these molecules (Figs. 3A and B) . These effects of the RBP-J deficient and control BMSCs on DC maturation were mediated by secretary factors, because similar phenomena were found in a transwell culture system in which DCs did not contact with BMSCs (Figs. 3C and D) . We also examined the expression of chemokine receptors on DCs (Hasegawa et al., 2000) . The result showed that co-culture of DCs with BMSCs +/− but not BMSCs −/− down-regulated the (C, D) The same experiment was performed as in (A) by using a transwell culture system in which DCs and BMSCs were cultured separately in the upper and lower chambers, respectively. (E, F) The expressions of CCR7 and CXCR4 on DCs in (A) were examined by FACS and MFI of these markers were compared between groups. (G, H) DCs in different groups were incubated in medium containing 1 mg/ml FITC-dextran for 60 min. Cells were then washed twice with cold PBS, and analyzed by FACS. MFI of dextran were compared between groups. (I) Cytokine production. DCs in (A) were collected by CD11c magnetic beads. The cells were seeded in 96-well plates and cultured for 5 days. Supernatants were collected and measured by ELISA for the indicated cytokines. Bars = means ± SD. *, P b 0.05, n = 6. expression of CCR7 and CXCR4 on DCs (Figs. 3E and F) . Moreover, by using FITC-conjugated Dextran, we found that BMSCs −/− -treated DCs showed lower antigen uptake capacity, but BMSCs +/− -treated DCs showed normal antigen uptake capacity compared with the controls (Figs. 3G and H) . The cytokine expression pattern of DCs treated with different BMSCs was determined by ELISA. The result showed that the control BMSCs (BMSCs +/+ and BMSCs +/− ) significantly suppressed IL-12 and TNF-α production while increased IL-10 production by DCs, but these roles were canceled upon RBP-J deletion in BMSCs (Fig. 3I) . These results indicated that while BMSCs could block DC maturation, RBP-J deficiency abrogated this effect of BMSCs.
RBP-J deficiency abrogated the ability of BMSCs to inhibit antigen presentation by DCs
To investigate whether RBP-J deficient BMSCs could block DC-mediated activation of T-cells, antigen presentation assays were performed. T-cells were isolated from lymph nodes of C57BL/6 mice immunized with OVA and loaded with CFSE. Syngeneic DCs were co-cultured with BMSCs +/− or BMSCs −/− while being loaded with the OVA antigen. After being isolated by using CD11c magnetic beads, the DCs and T-cells were then co-cultured, and the proliferation and activation markers expression of T-cells were examined. The results showed that while antigen-specific DCs co-cultured with BMSCs +/− strongly inhibited the proliferation of CD4 + and CD8 + T-cells, DCs co-cultured with RBP-J deficient BMSCs (BMSCs −/− ) maintained normal ability to stimulate the proliferation of antigen-specific T-cells (Figs. 4A, D) . Similarly, T-cells stimulated with DCs co-cultured with BMSCs +/− expressed low level of T-cell activation markers CD69 and IFN-γ, but T-cells stimulated with DCs co-cultured with BMSCs −/− expressed normal level of these molecules (Figs. 4B-D) . These results suggested that BMSCs without Notch signaling were deprived of the ability to interrupt the antigen presentation activity of DCs.
BMSCs without RBP-J could not inhibit DCs to prime T-cells in vivo
To examine the effects of RBP-J deficient BMSCs on immune responses in vivo, we employed two experiments. First, C57BL/ 6 mice were pre-immunized with OVA, and re-challenged at footpads with OVA-loaded DCs pre-co-cultured with BMSCs of different genotypes (BMSC-precultured). In the second experiment, C57BL/6 mice pre-immunized with OVA were rechallenged with OVA-loaded DCs at footpads, followed by BMSCs injection i.v. 3 h after DC inoculation (BMSC-injected) (Chiesa et al., 2011) . Three days after DC re-challenge, the draining lymph nodes of the mice were isolated and analyzed. The results showed that in both models, compared with mice treated with BMSCs +/− , the number of CD3 + T-cells increased remarkably in draining lymph nodes of mice treated with BMSCs −/− (Fig. 5A ). The proliferation of CD3 + T-cells was observed by using BrdU incorporation, and the result showed that the mice treated with BMSCs −/− showed significantly higher rate of T-cell proliferation in draining lymph nodes than the BMSCs +/− -treated mice (Figs. 5B, C) . By using GFP + DCs, we found that about 3-fold more DCs were homed in draining lymph nodes in BMSCs −/− -treated groups than the controls (Figs. 5D, E) . Furthermore, in the BMSCs −/− -treated mice, T-cells in the draining lymph nodes expressed higher levels of CD69 and IFN-γ than the BMSCs +/− -treated groups (Figs. 5F-I ). These data suggested that RBP-J deficient BMSCs were weaker in suppressing immune responses in vivo as compared with normal BMSCs.
We next examined the effect of different BMSCs on DCs in an allo-DTH immune reaction in vivo. DCs were pre-cultured with BMSCs with different genotypes, and were injected i.p. into mice suffering from allo-DTH. The result showed that while pre-culture with wild-type or RBP-J +/− BMSCs significantly repressed footpad swelling of BALB/c mice receiving the alloantigen, pre-culture with BMSCs −/− failed to do so (Fig. 5J) . These results further suggested that disruption of RBP-J abrogated the suppressive effects of BMSCs on immune responses.
IL-6 and PGE2 regulated by Notch signaling played an important role in the differentiation of DCs IL-6 induces an inhibitory signal for DC maturation through triggering the activation of Stat3 (Park et al., 2004 ). An RBP-Jbinding site was identified in the IL-6 promoter to regulate the expression of IL-6 (Palmieri et al., 1999) . IL-6 was measured in the supernatant of different BMSC cultures by using ELISA. Compared with BMSCs +/− , BMSCs −/− produced significantly lower level of IL-6 (Fig. 6A) . When BMSCs +/− cells were co-cultured with BM monocytes (BMM) (Spaggiari et al., 2009) , IL-6 level in the supernatant increased significantly. The level of IL-6 was still high when BMM was removed from the co-culture system, indicating that IL-6 was mainly secreted by BMSCs. In the case of BMSCs −/− , in contrast, the basal IL-6 level and the IL-6 level in the presence of BMM decreased significantly. We also examined IL-6 mRNA levels of BMSCs in the presence or absence of BMM. IL-6 mRNA expression was significantly lower in MSC −/− than in BMSCs +/− (Fig. 6B) . Binding of IL-6 to its receptor initiates cellular events including activation of Stat3 signaling and activation of Akt (Park et al., 2004) . DCs cultured with different BMSCs for 5 days were isolated by using CD11c magnetic beads and analyzed for the phosphorylation of Stat3 and Akt by Western blot. DCs co-cultured with BMSCs −/− showed significantly lower Stat3 or Akt phosphorylation than DCs co-cultured with BMSCs +/− (Fig. 6C) . These results suggested that the Notch signaling may regulate the expression of IL-6 in BMSCs to regulate DC maturation. Consistently, addition of IL-6 into the co-culture of BMSCs −/− and DCs reduced the expression of CD80, CD86, and MHC II by DCs, to a similar level to that of the BMSCs +/− co-culture (Figs. 6D and E) . On the other hand, inclusion of anti-IL-6 to the co-culture of BMSCs +/− and DCs enhanced the expression of CD80, CD86 and MHC-II by DCs (Figs. 6D and E) . BMSCs regulate DC maturation through the production of PGE2. PGE2 could also be an important mediator for the BMSC-mediated suppression of T-cell proliferation (supplementary Fig. S5 ). Disruption of RBP-J in BMSCs remarkably reduced PGE2 production, regardless of the absence or presence of BMM (Fig. 6F) . Treatment of BMSCs +/− with anti-IL-6 reduced PGE2 production, while treatment of BMSCs −/− cells with IL-6 increased PGE2 production (Fig. 6F) , suggesting that RBP-Jmediated signaling regulated PGE2 production by BMSCs.
Discussion
BMSCs regulate immune responses by interactions with a wide range of immune cells through direct cell-cell contacts and soluble factors. This property of BMSCs has been translated into potential therapies for human diseases such as aGvHD (Palmieri et al., 1999) . In this study, we show that the immuno-regulation function of BMSCs is under the control of Notch signaling. As far as we have tested, Notch signaling may modulate BMSC-mediated immuno-suppression through at least two types of cells, T-cells and DCs. BMSC infusion may lead to altered migration of T-cells and DCs in the secondary lymphoid organs and disease-targeted organs of aGvHD mice, contributing to immuno-suppression (Korngold and Sprent, 1985; Weng et al., 2010; Aggarwal and Pittenger, 2005; Viola et al., 2006) . This role of BMSCs was canceled upon RBP-J disruption. Also, RBP-J deficient BMSCs failed to inhibit the proliferation of T-cells that is critical for BMSCs to suppress T-cell activation (Glennie et al., 2005) . Moreover, RBP-J deficient BMSCs were not able to block DC maturation, therefore failed to abrogate DC-mediated T-cell activation. This might also play a critical role in the attenuation of immuno-suppression activity of BMSCs by RBP-J disruption. Giving the critical role of RBP-J in mediating canonical Notch signaling (Artavanis-Tsakonas et al., 1999) , our data suggest that RBP-J-mediated Notch signaling participates in the regulation of the immuno-suppression roles of BMSCs.
Many studies (Lee et al., 2009; Fischer et al., 2009 ) have reported that intravenously injected BMSCs are initially trapped in the lung. However, it has also been shown that pulmonary trapping of infused cells may be a transient phenomenon. Intravenously injected BMSCs or peripheral blood stem cells (PBSCs) accumulate initially in the lung when observed in an hour after injection (Gao et al., 2001; Daldrup-Link et al., 2004; Schrepfer et al., 2007) , and redistribute to liver, spleen, kidney and BM 48 h later (Gao et al., 2001; Daldrup-Link et al., 2004) .
Rochefort et al. found a 50-60% pulmonary accumulation of BMSCs 1 h after infusion and this percentage went down to about 30% 3 h post injection (Rochefort et al., 2005) . Kang et al. reported that intravenous injection of PBSCs had a high lung uptake at 30 min, and the initial lung uptake was cleared 2 h later after injection. At 4 h after the injection, the distributions of the intravenously injected PBSCs were 42.12% in spleen, 21.3% in liver and only 5.8% in lung (Kang et al., 2006) . In our experimental model, while many of the injected BMSCs were in the lung, a substantial fraction of cells could be found in the spleens and other organs of the recipient mice 2 days after the injection. Several reasons might be involved in this phenomenon. First, cell size has been considered as a key factor in the pulmonary trapping BMSCs. A single dose of 950 cGy irradiation might injure the pulmonary capillary endothelium and increase the pulmonary capillary filtration coefficient (Suzuki et al., 1999) , which may improve the passage of BMSCs. Second, BMSC infusion with two injections had been used in our experiments, which might result in an increased pulmonary passage as compared to a single injection. Third, BMSCs in the lethal aGvHD mice 2 days after the injection were likely to further located into spleen by splenic inflammation induced by aGvHD, like the intravenously injected neural stem cells (NSCs) reaching the lymph nodes of mice with intracerebral hemorrhage (ICH) or experimental autoimmune encephalomyelitis (EAE) (Lee et al., 2008; Einstein et al., 2007) .
Our results have also shown that the production of IL-6 and PGE2 is pivotal in Notch-mediated immuno-suppression effects of BMSCs on DCs. PGE2 inhibits T-cell activation and proliferation, and is synthesized by phospholipase A2 and COX from arachidonic acid released from cellular membrane phospholipids (Fitzpatrick and Soberman, 2001) . Two isoforms of COX have been found in many types of cells. COX-1 is expressed constitutively in most mammalian tissues and is responsible for housekeeping functions of PGs such as the regulation of gastric acid secretion. COX-2, in contrast, is an inducible form and is induced by a variety of cytokines during proinflammatory responses. A complex of NIC and RBP-J has been shown to bind to COX-2 promoter and elevate COX-2 expression in SC-M1 cells (Yeh et al., 2009 ). This finding was consistent with our results showing that the production of PGE2 was reduced significantly in BMSCs when RPB-J gene was knocked out.
IL-6 plays a major role in the regulation of immune response, hematopoiesis, inflammation and oncogenesis (Kishimoto, 2010) . A variety of transcription factors including AP1, C/EBP . of C57BL/6 splenocytes on day 0 and challenged on day 7 and day 14 at the hind footpad by injecting the same antigens. DCs from C57BL/6 mice were pre-cultured with PBS or BMSCs (BMSC-DC), and injected i.p. on days − 6, − 4, 0, 3, and 6. Footpad thickness was measured on days 8 and 15. The extent of swelling was calculated as the thickness of the right footpads (receiving C57BL/6 splenocytes) minus the baseline thickness of the left footpads. Bars = means ± SD. *, P b 0.05, n = 6. and nuclear factor (NF)-κB are involved in the regulation of IL-6 expression (Plaisance et al., 1997) . The NF-κB family of proteins is the key regulator of IL-6 gene transcription, and conserved binding motifs for NF-κB were identified between − 73 and −64 bp upstream to the transcriptional start site of the IL-6 promoter (Libermann and Baltimore, 1990) . A RBP-J protein-binding motif has been identified within the NF-κB-binding sites, and RBP-J can bind to this region (Plaisance et al., 1997; Palmieri et al., 1999) . RBP-J has been shown as a constitutive silencer of the IL-6 gene in the absence of NF-κB, and functions as a modulator of NF-κB binding and transactivation, presumably by limiting the access of NF-κB to DNA (Plaisance et al., 1997; Palmieri et al., 1999) . However, RBP-J-deficient murine macrophages produced less IL-6 upon LPS stimulation (Wongchana and Palaga, 2012; Wang et al., 2010b) . Overexpression of NIC in RAW264.7 macrophages resulted in significantly higher IL-6 expression than the control, which could be completely abrogated by a NF-κB inhibitor (Wongchana and Palaga, 2012) . Consistently, in the current study, IL-6 expression in BMSCs decreased significantly upon RBP-J gene knockout (Osipo et al., 2008) . BMSCs interfere with DC differentiation, maturation and function. IL-6 was initially thought as the main effector in the inhibition of DC differentiation by BMSCs. Djouda et al. reported that murine MSCs secreted high level of IL-6, which down-regulates the expression of MHC II, CD40, and CD86 on mature DCs and reduces T-cell proliferation. However, a recent study showed the critical role of PGE2 in MSC-mediated immuno-suppression (Glennie et al., 2005) . Bouffi and colleagues found that IL-6 deficient MSCs exhibited the lowest suppressive effect and did not significantly reduce the severity of arthritis. In their experimental model, PGE2 expression was reduced significantly in IL-6 −/− MSCs, which indicated that the immuno-regulatory function of MSCs was mainly attributed to IL-6-dependent secretion of PGE2 (Bouffi et al., 2010) . However, an inhibitor of PGE2 can reverse the inhibition of DC differentiation by BMSCs despite the presence of high amount of IL-6 (Dong et al., 2010) , suggesting that PGE2 may play a more critical role than IL-6 (Wang et al., 2010a; Kumar et al., 2012) .
The Notch signaling pathway plays a pivotal role in regulating cell differentiation during development. In recent years, increasing evidence has been accumulated showing that Notch signal modulates the direction of immune responses by regulating the activation of various immune cells. In the current study, we show that Notch signal is required for BMSCs to exert their immuno-suppression roles. These data provide further evidence that Notch signal regulates immune regulatory effects of not only immune cells, but also non-immune cells such as BMSCs.
Figure 6 IL-6 and PGE2 played the key roles in the regulation of DCs by BMSCs through Notch signaling. (A) IL-6 production. BMSCs were cultured alone or in combination with BM monocytes (BMM). After 5 days of culture, supernatants were collected and IL-6 was measured by ELISA. In the (+ → −) group, BMM was removed after co-cultured for 3 days, and then the BMSCs were cultured for another 5 days before IL-6 in the supernatant was measured. (B) Total RNA of BMSCs in (A) was prepared, reverse-transcribed, and analyzed by real-time PCR for relative level of IL-6 mRNA, with β-actin as an internal control. (C) DCs co-cultured with BMSCs of different genotypes were isolated by magnetic beads. Total cell lysates were prepared and subjected to Western blot analysis for detecting the phosphorylated Stat3 (P-Stat3), Stat3, phosphorylated Akt (P-Akt) and Akt, with β-actin as a control. (D, E) DCs from BM monocytes were co-cultured with BMSCs of different genotypes. IL-6 or an anti-IL-6 antibody was added into the medium as indicated. After 9 days of culture, DCs were stimulated by LPS and collected by CD11c magnetic beads, and the expressions of CD80, CD86 and MHC II were analyzed by FACS. MFI of these markers were compared between groups. (F) BMSCs were cultured in the absence or presence of BMM. The production of PGE2 was evaluated in the culture supernatants by ELISA. In some experiment, IL-6 or an anti-IL-6 antibody was added into the medium. Bars = means ± SD. *, P b 0.05, n = 6.
